Biomorphik App with MyFiziq technology released on Google and Apple

By Trevor Hoey. Published at Jan 5, 2021, in Technology

Just a fortnight after MyFiziq Limited (ASX:MYQ) announced that the Biomorphik App integrated with MyFiziq’s technology had been registered with Google Play and Apple Store for release approval, management has today confirmed that the app has been released on both platforms.

In line with the initial product release, Biomorphik will commence a comprehensive B2C marketing strategy to draw users to the new platform with the first stage allowing people to monitor their bodies closely and pre-empt potential issues before they become prohibitive to the user’s health.

At its core, Biomorphik is a behavioural change company with a key goal being to improve the health and wellness of people at a whole-of-society level through better creation, measurement, storage, analysis, and access to data.

The technology is highly complementary with MyFiziq’s patented proprietary image capture and dimensioning technology that enables its users to check, track, and accurately assess their dimensions and vital signs using only a smartphone privately on-device.

Pricing provides highly competitive option for consumers

Under the terms of the commercial contracts, Biomorphik has given an undertaking to deliver 100,000 active monthly users to MyFiziq.

In the event this target is not achieved, MyFiziq has a right to terminate the agreements between the parties.

Biomorphik will offer both a monthly subscription at AUD$22.99 per month for unlimited scans, as well as a yearly subscription payment option with a significant discount at AUD$142.99 per year for unlimited scans to consumers.

This pricing represents a highly attractive offering relative to other players in the sector.

On the score of affordability, MyFiziq chief executive Vlado Bosanac said, ‘’When you consider a single Dexa body composition scan can cost up to AUD$80.00, the monthly fee of AUD$22.99 is an extremely cost-effective option.

‘’The user can scan as many times as they wish to track body composition changes, empowering the user to make better decisions regarding their health and wellness.’’

Bosanac went on to say, ‘’With the applications now live and available for download, Nathaniel (CEO of Biomorphik) is programming a well-formulated marketing approach to the release over the first quarter of 2021.

‘’Once this commences, we will assist Nathaniel and Biomorphik with their campaign as needed, and I believe this will be the first of the releases to take a more aggressive approach to customer on-boarding as it forms such an integral part of their customer journey and retention, through real data and supervision.

‘’I encourage our shareholders and stock followers to try the Biomorphik app now that it has been released on the Australian iOS and Google Play app stores.”

Where to invest $1,000 right now

S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.

Conflict of Interest Notice

S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.

Publishers Notice

The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.

Australian ASX Small Cap stocks | Why is Australia’s leading small cap publication

Founded seven years ago, is Australia’s leading and longest standing website for investor and finance news, education and expert opinion.

Published by StocksDigital, Finfeed was created to report daily on the comings and goings of ASX listed stocks in the small cap market.

As the first digital publication dedicated specifically to this space, Finfeed soon became the most trusted publication in the market, quickly garnering over two million page views – a number that continues to rise. provides its readers with informative articles that tackle the latest in market moving #ASX small cap news, plus exclusive content you won’t find anywhere else. It is aimed at those with an interest in investing, market education, company performance, start-ups and much more. is the only media organisation operating under the strength of a Financial Services License and is backed by leading journalists and analysts all with brands of their own.

The website aims to inform, educate and entertain with content that drills down into the heart of financial matters.

Finfeed is a leading source of investor and market information, with everything investors need to know about how to invest written in a way that anyone can understand. 

Over the years, the website has expanded beyond exclusively reporting on small caps, to profile Australia’s leading ASX listed small, mid and large caps as well as some of the country’s most successful CEOs and business leaders to find out what makes them tick.

Every day you will find fresh content covering:

Fast Facts

Over 4,000 articles published

Over 2.3 Million Page Views and counting

Over 10,000 followers on social media

Subscriber list growing by 2% monthly

Thanks for subscribing!